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Abstract
A psoriatic patient with absolute deficiency of IgA is reported. The manifesta­
tions of poriasis appeared at the age of 6 months and proved to be resistant to 
various treatments. The present case report and the data available in the literature 
on IgA and psoriasis all converge on the hypothesis that IgA is a systemic factor 
which belongs to the ‘off switches’ of the psoriatic process.
Inflammation, epidermal proliferation and abnormal dif­
ferentiation of the epidermis are the well-known abnormali­
ties in the pathogenesis of psoriasis. The immunology of 
psoriasis has been reviewed recently [1]. One part of the 
immunology in psoriasis regards the ‘noncellular compo­
nents’. An important observation, highlighting the rele­
vance of non-cellular systemic factors in psoriasis is the 
fact that serum from patients with stable psoriasis repressed 
the Kobner reaction, whereas serum derived from patients 
with unstable relapsing psoriasis failed to suppress this 
phenomenon [2]. This observation may indicate that serum 
factors in chronic stable psoriasis have an antipsoriatic 
potential, protecting the patient against progression.
Functionally, serum factors may modulate chemotaxis 
of monocytes and neutrophils and may interfere with angio- 
neogenesis and proliferation of fibroblasts [3 -6 ]. Non-cel­
lular systemic factors which might be involved in the im- 
munopathogenesis o f psoriasis are numerous. It has been 
suggested that IgA and IgA immune complexes are in­
volved in the pathogenesis o f psoriasis [7 -9 ] .
Recently, we had the opportunity to treat a patient with 
a com plete deficiency of IgA who had psoriasis of the 
chronic plaque type with an unusual course: initiation of 
psoriasis was at the age of 6 months, and the course was 
resistant to various treatments.
Case Report
A 23-year-old patient presented at our department with psoriasis. 
Already at the age of 6 months his parents had consulted the regional 
dermatologist who diagnosed the baby as having psoriasis inversa 
with typical psoriatic plaques at other localizations. During childhood 
he had episodes of psoriasis guttata. The skin lesions had persisted 
although the patient had been treated with topical corticosteroids, tar, 
dithranol, cyclosporin and phototherapy. (
As a child between his second and twelfth year o f life, the patient 
had recurrent episodes of otitis media, rhinitis and bronchitis. At the 
age o f 5 years, he had a submandibular lymphadenitis. At the age of 15 
years, he had furunculosis, lymphadenitis and recurrent sinusitis. No 
abnormalities were observed with respect to T-cell phenotype and T- 
cell proliferation. However, an absolute deficiency o f IgA was shown: 
less than 1 unit/ml (normal range 5 0 -2 5 0  units/ml). Total IgG, IgM 
and IgE were in the normal range, !gG4 was slightly reduced being 
17 units/ml (normal >20 units/ml).
At presentation the patient had classical sharply demarcated ery­
thematous plaques, compatible with the diagnosis of psoriasis inversa, 
localized in the joint and.perianogenital regions, the axillae and umbi­
licus. On the scalp, elbows and legs he had sharply demarcated ery- 
thematosquamous plaques and some punctate papules with a classical 
symmetrical distribution, compatible with the diagnosis of stable 
chronic plaque psoriasis. The course of the disease did not indicate 
any correlation between these recurrent infections and exacerbations 
of psoriasis.
Microbiological investigation of scrapings taken from the joints 
revealed Staphylococcus aureus. No fungi could be demonstrated by 
direct investigation and cultures. Histological investigation of a
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biopsy taken from the left elbow revealed the classical picture of an 
active lesion with pronounced acanthosis, parakeratosis, a mixed 
inflammatory infiltrate and prominent micropustules o f Kogoj and 
microabscesses o f Munro.
The patient was admitted to the inpatient department for treatment 
with dithranol paste. However, due to irritation, already at low 
concentrations, the treatment had to be changed to a short-contact 
schedule with dithranol creams, tar preparations, corticosteroids, 
hydrocolloid dressing and UVB phototherapy. Due to insufficient 
improvement, additional treatment with acitretin ( 3 5 - 5 0  mg/day) 
was given. Following a 10-week admission, the intensified combined 
treatments had resulted in a considerable improvement, although total 
clearing was not reached.
Discussion
groups is the correlation betw een increased serum levels of 
IgA and the extent o f the skin m anifestations and severity 
of arthritis [18, 25], H ow ever, it has been reported that pso­
riasis with arthropathy m ay coexist with a selective IgA 
deficiency [26], Two groups have reported on decreased 
IgA levels in psoriatic patients [27, 28], The correlation 
between disease activity and IgA levels [18, 25] suggests 
that IgA is o f significance in the pathogenesis of psoriasis. 
It is attractive to hypothesize that IgA  is an ‘antipsoriatic 
factor’. Indeed, relatively h igh  levels o f IgA have been 
measured in chronic long-standing plaque psoriasis and in 
patients with extensive lesions, in contrast to the low levels 
of IgA in relapsing and guttate-type psoriasis [18]. Patients 
with decreased or undetectable IgA levels and psoriasis 
[2 6 -2 8 ] m ay have an unfavorable prognosis according to
The accumulation of T lymphocytes and polymorphonu- this hypothesis
clear leukocytes and the abnormal functioning of these cells The present case report is in line with a protective role of
are thought to be relevant and crucial aspects of the patho- IgA with respect to the relapse o f psoriasis. The unusual 
genesis of psoriasis [1, 10], Both cell types have been course -  onset at the age of 6 m onths and the unstable fea- 
reported to possess receptors for the Fc portion of the IgA tures, characterized by extrem e dithranol sensitivity and 
molecule [11-14], With respect to functioning of the poly- therapy resistance -  in a patient with IgA deficiency may 
morphonuclear leukocyte, it has been shown that IgA para- suggest that IgA  indeed belongs to the ‘o ff switches’ o f the 
proteins and polymeric forms of IgA inhibit the chemotaxis psoriatic process. How ever, it is rem otely possible that the 
and the bactericidal activity of these cells [15-17]. Schro- episodes of recurrent infections m ight have been respon­
der et al. [18] reported on the neutrophil chemotaxis inhi- sible for the onset o f psoriasis in early childhood, 
biting activity o f sera from patients with psoriasis and other 
neutrophilic dermatoses. The inhibition of chemotaxis
proved to correlate with increases in serum IgA. Patients 
with chronic stationary psoriasis showed high IgA levels 
and reduced neutrophil chemotactic activity whereas those 
patients with relapsing psoriasis had normal IgA levels and 
increased neutrophil chemotactic activity [18]. This obser­
vation lends support for the supposition that an increase in 
serum IgA might be an antipsoriatic mechanism, stabilizing 
the psoriatic process. However, although neutrophil chemo­
taxis inhibiting activity of sera from patients with psoriasis 
has been shown to depend upon IgA polymeric forms in 
vitro, it is not clear whether this is important in vivo [19].
Different groups have reported that serum IgA levels are 
increased in psoriasis [8 , 2 0 -2 4 ] . Circulating IgA immune 
complexes have also been reported to be increased in psori­
asis [9, 25]. Guilhou et al. [8] reported that the increase in 
IgA is specific for psoriasis as no patient with eczema had 
such an increase. By these authors, the increase in IgA-con- 
taining immune complexes was observed in 67% of a group 
of psoriatics whereas a similar increase was found in only 1 
out of 25 patients with hyperkeratotic disorders. Fraser et 
al [20] reported increased levels of IgA in patients with 
dermatitis herpetiformis, acne vulgaris, rosacea and discoid 
lupus erythematosus. A consistent observation by various
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